Clinical Trial Update: Phase II Dose-Finding of Oral SSS17 for Anemia in Non-Dialysis CKD [Phase 2]

View source ↗

Summary

A Phase II dose-finding study of the oral agent SSS17 for anemia in non-dialysis chronic kidney disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia of Chronic Kidney Disease

Drugs mentioned

• SSS17

Snippet

Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD. | Conditions: Anemia in Pre-Dialysis Patients | Phase 2 | Status: COMPLETED